XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ 53,739 $ 21 $ 319,115 $ 44 $ (265,441)
Beginning balance, shares at Dec. 31, 2019   20,851,531      
Issuance of common stock upon exercise of options 40   40    
Issuance of common stock upon exercise of options, shares   24,687      
Issuance of common stock with restricted stock units and awards 58   58    
Issuance of common stock with restricted stock units and awards, shares   40,931      
Stock-based compensation expense 1,447   1,447    
Foreign currency translation adjustments (71)     (71)  
Net loss (13,844)       (13,844)
Ending balance at Mar. 31, 2020 41,369 $ 21 320,660 (27) (279,285)
Ending balance, shares at Mar. 31, 2020   20,917,149      
Beginning balance at Dec. 31, 2020 113,905 $ 26 430,781 41 (316,943)
Beginning balance, shares at Dec. 31, 2020   25,722,984      
Issuance of common stock upon exercise of options 761   761    
Issuance of common stock upon exercise of options, shares   77,892      
Issuance of common stock with restricted stock units and awards 47   47    
Issuance of common stock with restricted stock units and awards, shares   33,332      
Stock-based compensation expense 2,685   2,685    
Foreign currency translation adjustments 11     11  
Net loss (10,407)       (10,407)
Ending balance at Mar. 31, 2021 $ 107,002 $ 26 $ 434,274 $ 52 $ (327,350)
Ending balance, shares at Mar. 31, 2021   25,834,208